FDA Inspection 974061 — ADMA Biologics, Inc
The FDA completed an inspection of ADMA Biologics, Inc on March 3, 2016 in Boca Raton, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 3, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Boca Raton, FL (United States)